VLE Therapeutics Revenue and Competitors

Vaccines, CGTs, and other advanced therapeutics are taking too long to reach patients. Scientists want to move faster, but external manufacturers prioritize ‘contracts’ over the need for innovation and speed in GMP manufacturing. The promise of patient-focused partnerships remains out of reach until now. *Speed through Science* VLE is led by the brightest scientific minds and powered by iACHIEVE© and BioACHIEVE© our digital and process science platforms. For every medicine, we redefine CMC, tech transfer, and GMP operations through digitization and scientific excellence creating a new frontier for medicine acceleration and a new state-of-the-art for GMP manufacturing. *Patient-Focused Partnerships* We constantly strive to understand the unique clinical and CMC landscape of every medicine we work on, enabling us to deliver the manufacturing breakthroughs our partners need to achieve audacious supply chain goals that truly serve patients. *Digital First GMP* Our expertise in manufacturing science and GMP operations is accentuated by our first-in-class digital strategy – iACHIEVE©. By digitizing our process, analytical and manufacturing science breakthroughs we can deliver medicines with the speed that patients deserve and the precision regulators demand.